Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 21, 2018
Pharmacy Choice - News - Drug Delivery Systems - July 21, 2018

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 95     Next >>     Go To Page:

7/21/18 - Patent Issued for Injector Training Device (USPTO 10013895)
By a News Reporter-Staff News Editor at Investment Weekly News A patent by the inventors Swanson, Kevin David; Sund, Julius, filed on March 12, 2014, was published online on July 3, 2018, according to news reporting originating from Alexandria, Virginia, by VerticalNews correspondents. Patent number 10013895 is assigned to Antares Pharma Inc..
7/20/18 - Cellectar Reports 94% Reduction in Overall Tumor Volume in Waldenstrom Macroglobulinemia Patient in Phase 2 CLR 131 Clinical Study
MADISON- Cellectar Biosciences, a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announces that a patient in the lymphoplasmacytic lymphoma arm with advanced Waldenstrom macroglobulinemia, enrolled in the CLR 131 Phase 2 trial, showed a 94% reduction i
7/20/18 - Data on Drug Delivery Systems Reported by Researchers at Tohoku University (In situ formation of injectable chitosan-gelatin hydrogels through double...
Data on Drug Delivery Systems Reported by Researchers at Tohoku University. According to news reporting out of Miyagi, Japan, by NewsRx editors, research stated, "Rapid clearance and low ocular bioavailability are drawbacks of conventional ophthalmic eye drops. Our news journalists obtained a quote from the research from Tohoku University, "The fea
7/20/18 - Dr. Reddy's Announces the Launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg in the U.S. Market
HYDERABAD, India& PRINCETON, N.J. Dr. Reddy s Laboratories Ltd. today announced the launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg, an over-the-counter therapeutic equivalent generic version of Nexium 24 HR Capsules in the United States market as approved by the U.S. Food and Drug Administration. The combined market
7/20/18 - FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation
The U.S. Food and Drug Administration today approved Tibsovo tablets for the treatment of adult patients with relapsed or refractory acute myeloid leukemia who have a specific genetic mutation. "Tibsovo is a targeted therapy that fills an unmet need for patients with relapsed or refractory AML who have an IDH1 mutation," said Richard Pazdur, M.D
7/20/18 - Findings on Drug Delivery Systems Detailed by Investigators at University of Eastern Finland (Implications of melanin binding in ocular drug delivery)
By a News Reporter-Staff News Editor at Drug Week Investigators publish new report on Drugs and Therapies- Drug Delivery Systems. According to news reporting originating in Kuopio, Finland, by NewsRx journalists, research stated, "Pigmented ocular tissues contain melanin within the intracellular melanosomes. The news reporters obtained a quote fr
7/20/18 - Global Infusion Pump Market by Product, Application and End-User to 2023 - CAGR to Grow at 6% - Increasing Adoption of Refurbished and Rental Infusion Pumps is Restraining Growth
The "Infusion Pump Market by Product, Application, End User- Global Forecast to 2023" report has been added to ResearchAndMarkets.com' s offering. The infusion pumps market is expected to reach USD 15.89 billion by 2023 from USD 11.9 billion in 2018, at a CAGR of 6%. In addition, untapped, emerging markets such as India and China and the growing ad
7/20/18 - Global Novel Drug Delivery Systems Market 2018 Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast to 2025
"\"Novel Drug Delivery Systems Market\ "" WiseGuyReports.com adds Novel Drug Delivery Systems Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025 reports to its database.. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East& Africa. North A
7/20/18 - Investigators from Tokyo University of Science Release New Data on Fullerenes (Scanning Techniques for Nanobioconjugates of Carbon Nanotubes)
Our news journalists obtained a quote from the research from the Tokyo University of Science, "Various biological applications using the CNT nanobioconjugates, for example, drug delivery systems and nanobiosensors, have been proposed by many authors. The news correspondents report that additional information may be obtained from K. Umemura, Tokyo..
7/20/18 - Investigators from University of Auckland Zero in on Drug Delivery Systems (Overcoming ocular drug delivery barriers through the use of physical...
Financial supporters for this research include Health Research Council of New Zealand, Buchanan Charitable Foundation. Our news editors obtained a quote from the research from the University of Auckland, "Various pharmaceutical strategies, such as novel formulations and physical force-based techniques, have been investigated to weaken these barrier
7/20/18 - Janssen Announces U.S. FDA Approval of SYMTUZATM, the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
TITUSVILLE- The Janssen Pharmaceutical Companies of Johnson& Johnson today announced the U.S. Food and Drug Administration has approved SYMTUZATM, the first and only complete, darunavir-based single-tablet regimen for the treatment of human immunodeficiency virus type 1 in treatment-naive and certain virologically suppressed adults.
7/20/18 - Mayne Pharma Launches Generic Kapvay in the U.S.
Greenville, N.C.- Mayne Pharma Group Limited is pleased to announce the launch of clonidine extended-release tablets, 0.1 mg in the United States. Mayne Pharma directly markets more than 60 products and has a growing pipeline of approximately 30 products targeting U.S. markets with IQVIA sales greater than $5 billion. Mayne Pharma expects several p
7/20/18 - New Phase 3 Data Show Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients With Moderately to Severely Active Ulcerative Colitis
Takeda Pharmaceudicals issued the following news release:. Takeda Pharmaceutical Company Limited today announced top-line results from the VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of vedolizumab for maintenance therapy in adult patients with moderately to severely active...
7/20/18 - Patent Application Titled "Thin Film with Non-Self-Aggregating Uniform Heterogeneity and Drug Delivery Systems Made Therefrom" Published Online...
Patent Application Titled "Thin Film with Non-Self-Aggregating Uniform Heterogeneity and Drug Delivery Systems Made Therefrom" Published Online. By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors Yang, Robert K.; Fuisz, Richa
7/20/18 - PureTech Health Announces Collaboration with Roche to Advance Technology for Oral Administration of Antisense Oligonucleotides
PureTech Health plc, a clinical-stage biopharmaceutical company developing novel medicines focused on the Brain-Immune-Gut Axis, today announced that it has entered into a multiyear collaboration with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., to advance PureTech s milk-derived exosome platform technology for the oral administration of
7/20/18 - Recent Research from University of Douala Highlight Findings in Drug Delivery Systems (Maleimide-acetylcholine headed bolaamphiphilic vesicles made...
Recent Research from University of Douala Highlight Findings in Drug Delivery Systems. According to news reporting out of Douala, Cameroon, by NewsRx editors, research stated, "Based on ricinoleic acid, two asymmetric bolaamphiphiles with unsymmetrical hydrophobic skeletons and two different hydrophilic head groups were designed and synthesized.
7/20/18 - Statement from FDA Commissioner Scott Gottlieb, M.D., on agency's efforts to encourage the development of and broaden access to generic versions of opioid analgesics that are formulated to deter abuse
One of the ways that the U.S. Food and Drug Administration is working to address the opioid epidemic is by encouraging the development of opioid analgesic products that are harder to manipulate and abuse. Opioids with abuse-deterrent formulations are intended to make certain types of abuse, such as crushing a tablet to snort or dissolving a capsu
7/20/18 - Transdermal Drug Delivery System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2025
New Study on "2018-2025 Transdermal Drug Delivery System Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast" added to Wise Guy Reports Database. Global Transdermal Drug Delivery System Industry. New Study on "2018-2025 Transdermal Drug Delivery System Market Global Key Player, Demand, Growth, Opportunities and Analysis Fo
7/20/18 - University of Texas - Austin Reports Findings in Drug Delivery Systems (Peptides as drug delivery vehicles across biological barriers)
By a News Reporter-Staff News Editor at Drug Week Current study results on Drugs and Therapies- Drug Delivery Systems have been published. Financial support for this research came from National Heart, Lung, and Blood Institute. The news correspondents obtained a quote from the research from the University of Texas- Austin, "Due to their intrinsic
7/20/18 - Upsher-Smith Launches Vigabatrin for Oral Solution under the Brand Name Vigadrone
Maple Grove- Upsher-Smith Laboratories, LLC today announced the launch of Vigadrone for Oral Solution, 500 mg, a fully substitutable, AA-rated generic version of Sabril powder for oral solution. Upsher-Smith partnered with Aucta Pharmaceuticals, LLC for product development and manufacturing. Vigadrone is supported by Upsher-Smith's Access Pathways.
7/19/18 - Aequus Announces Expansion of Market Opportunity for its Long Acting Anti-Nausea Transdermal Patch
Aequus Pharmaceuticals Inc. is pleased to announce a recent expansion of the market opportunity for its reformulated anti-nausea transdermal patch, AQS1303, into the European market. Previously, the focus had been on the United States and Canada, where Diclegis / Diclectin has been approved since 2013 and 1983, respectively. Following a revi
7/19/18 - Altasciences Participates in Clinical Trial for Type 1 Diabetes Mellitus [Syrian Arab News Agency]
Altasciences is pleased to have partnered with Xeris Pharmaceuticals, a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables, on a randomized, controlled, single blind, two-way crossover study to evaluate the efficacy and safety of their...
7/19/18 - FDA approves Janssens Symtuza single-tablet regimen for HIV-1 [All Iraq News Agency (AIN)]
The US Food and Drug Administration has granted approval to Janssen Pharmaceutical Companies single-tablet regimen Symtuza to treat human immunodeficiency virus type 1. Cobicistat, emtricitabine and tenofovir alafenamide are provided by Gilead Sciences under a licensing agreement with Janssen. Janssen Pharmaceutica Infectious Diseases, Late...
7/19/18 - FDA Approves New Indications for ZOMACTON (somatropin) as Ferring Plans Launch of Needle-Free Delivery System
Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications:. It is estimated that around 3-5% of children in the United States have short stature, defined as a height below the 3rd percentile. Parents struggle to deliver their child s dai
7/19/18 - First-time surgery saves life of 64-year-old expat in UAE [Khaleej Times (United Arab Emirates)]
Doctors at Rashid Hospital save the life of an eelderly patient by performing a first-of-its-kind procedure in Dubai- Supplied photo. The Rashid Hospital successfully carried out the first pulmonary embolism catheter directed clot lysis procedure in Dubai saving the life of a 64- year-old Arab expatriate. Dr Shibu Bahuleyan, cardiologist at the Ras
Articles(s): 1 - 25 of 95     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415